NCT03227237 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Herrenkohl TI, Maguin E, Hill KG, Hawkins JD, Abbott RD, Catalano RF
Developmental risk factors for youth violence. J Adolesc Health. 2000 Mar;26(3):176-86.
Hoeve M, Stams GJ, van der Put CE, Dubas JS, van der Laan PH, Gerris JR
A meta-analysis of attachment to parents and delinquency. J Abnorm Child Psychol. 2012 Jul;40(5):771-85. doi: 10.1007/s10802-011-9608-1. Review.
Mednick BR, Baker RL, Carothers LE
Patterns of family instability and crime: The association of timing of the family's disruption with subsequent adolescent and young adult criminality. J Youth Adolesc. 1990 Jun;19(3):201-20. doi: 10.1007/BF01537887.

Assess the Impact of Strained Interpersonal Relationship (IPR) With Parents on Juvenile Delinquency Among Children Residing in Selected Delinquent Home Ambala, Haryana"

Details for clinical trial NCT03227237

Clinical trial NCT03227237 - References